Does ELRANATAMAB-BCMM Cause C-reactive protein increased? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of C-reactive protein increased have been filed in association with ELRANATAMAB-BCMM. This represents 1.8% of all adverse event reports for ELRANATAMAB-BCMM.
10
Reports of C-reactive protein increased with ELRANATAMAB-BCMM
1.8%
of all ELRANATAMAB-BCMM reports
0
Deaths
6
Hospitalizations
How Dangerous Is C-reactive protein increased From ELRANATAMAB-BCMM?
Of the 10 reports, 6 (60.0%) required hospitalization.
Is C-reactive protein increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ELRANATAMAB-BCMM. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does ELRANATAMAB-BCMM Cause?
Cytokine release syndrome (115)
Death (51)
Pyrexia (46)
Fatigue (31)
Neoplasm progression (31)
Cytomegalovirus infection reactivation (29)
Malignant neoplasm progression (27)
Off label use (27)
Immune effector cell-associated neurotoxicity syndrome (26)
Infection (25)
What Other Drugs Cause C-reactive protein increased?
METHOTREXATE (5,999)
ADALIMUMAB (4,579)
RITUXIMAB (4,060)
ETANERCEPT (3,922)
TOCILIZUMAB (3,719)
INFLIXIMAB (3,621)
LEFLUNOMIDE (3,574)
HYDROXYCHLOROQUINE (3,552)
ABATACEPT (3,451)
SULFASALAZINE (3,096)
Which ELRANATAMAB-BCMM Alternatives Have Lower C-reactive protein increased Risk?
ELRANATAMAB-BCMM vs ELTROMBOPAG
ELRANATAMAB-BCMM vs ELTROMBOPAG OLAMINE
ELRANATAMAB-BCMM vs ELUXADOLINE
ELRANATAMAB-BCMM vs ELVITEGRAVIR
ELRANATAMAB-BCMM vs EMAPALUMAB